H-ras antisense oligodeoxynucleotide isis 2503

H-ras antisense oligodeoxynucleotide isis 2503 Uses, Dosage, Side Effects, Food Interaction and all others data.

H-ras antisense oligodeoxynucleotide isis 2503 is under investigation in clinical trial NCT00004193 (H-ras antisense oligodeoxynucleotide isis 2503 in Treating Patients With Metastatic And/or Locally Recurrent Colorectal Cancer).

Trade Name H-ras antisense oligodeoxynucleotide isis 2503
Generic ISIS 2503
ISIS 2503 Other Names H-ras antisense oligodeoxynucleotide isis 2503
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
H-ras antisense oligodeoxynucleotide isis 2503
H-ras antisense oligodeoxynucleotide isis 2503

Innovators Monograph

You find simplified version here H-ras antisense oligodeoxynucleotide isis 2503


*** Taking medicines without doctor's advice can cause long-term problems.
Share